Showing results (1-10 of 52) with videos related to
Sort By:
Pageof 6
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 12, 1999
[Tuberculosis of the breast]K Ohgaki, T HoriJournal of Clinical & Laboratory Immunology|May 1, 1989
Induction by cyclophosphamide administration of two distinct anti-tumor effector cells at tumor site and spleen of mice transplanted with MOPC-104E plasmacytomaY Nio, K Ohgaki, T TobeCancer Immunology, Immunotherapy : CII|January 1, 1984
Antitumor and therapeutic effects of spleen cells from tumor-bearing mice cultured with T cell growth factor and soluble tumor extractN Kan, K Ohgaki, T Inamoto, et al.In Vivo (Athens, Greece)|May 1, 1988
Selective accumulation of a new antineoplastic agent, K-18 (human immunoglobulin conjugated melphalan), in Ehrlich carcinoma transplanted in miceY Nio, S Imai, K Ohgaki, et al.Journal of Clinical & Laboratory Immunology|July 1, 1989
Lymphocytes anticancer chemosensitivity testing in vitro--an approach to predict immunosuppressive effect of anticancer agentsY Nio, S Imai, T Shiraishi, et al.The Journal of Nutrition|June 1, 1982
Effect of vitamin E as an immunopotentiation agent for mice at optimal dosage and its toxicity at high dosageT Yasunaga, H Kato, K Ohgaki, et al.Nihon Geka Gakkai Zasshi|April 1, 1989
[Anti-tumor effect of fluoropyrimidines on human tumor cell lines transplanted in nude mice with CCl4-induced liver dysfunction]Y Nio, S Imai, T Shiraishi, et al.Anticancer Research|May 1, 1989
The inhibitory effect of a conjugate of human immunoglobulin G and melphalan, K18, on DNA synthesis of human tumor cellsT Shiraishi, Y Nio, S Imai, et al.Anticancer Research|January 1, 1989
Binding and internalization of human immunoglobulin G conjugated with melphalan (K18) to human tumor cell linesY Nio, T Shiraishi, S Imai, et al.Genes, Chromosomes & Cancer|April 30, 1999
Localization of tumor suppressor gene associated with distant metastasis of urinary bladder cancer to a 1-Mb interval on 8p22K Ohgaki, A Iida, O Ogawa, et al.Pageof 6